<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Uncontrolled complement activation may be of immunopathological importance in <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> of the gastrointestinal tract </plain></SENT>
<SENT sid="1" pm="."><plain>Expression of membrane bound factors that regulate complement activation was therefore studied in situ </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Frozen tissue specimens were obtained from patients with Helicobacter pylori <z:hpo ids='HP_0005263'>gastritis</z:hpo>, <z:e sem="disease" ids="C0007570" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">coeliac disease</z:e>, <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, or <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, and from histologically <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="3" pm="."><plain>Sections were examined by immunofluorescence with monoclonal antibodies to protectin (CD59), decay accelerating factor (DAF), and membrane cofactor protein (<z:chebi fb="17" ids="50099">MCP</z:chebi>) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Protectin and <z:chebi fb="17" ids="50099">MCP</z:chebi> were widely expressed in <z:mpath ids='MPATH_458'>normal</z:mpath> and diseased mucosae </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="17" ids="50099">MCP</z:chebi> was generally observed basolaterally on <z:hpo ids='HP_0000001'>all</z:hpo> epithelial cells, whereas apical protectin expression was more intense on the epithelium of <z:mpath ids='MPATH_458'>normal</z:mpath> colonic mucosa than in the <z:mpath ids='MPATH_458'>normal</z:mpath> duodenum (p = 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Epithelial DAF and to some extent protectin were upregulated in <z:hpo ids='HP_0005263'>gastritis</z:hpo>, <z:e sem="disease" ids="C0007570" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">coeliac disease</z:e>, and <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Areas of the stomach with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> expressed DAF, unlike the adjacent gastric epithelium </plain></SENT>
<SENT sid="8" pm="."><plain>Parietal cells of the gastric body expressed neither protectin nor DAF </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Epithelial complement inhibitory molecules were expressed differently at various <z:mpath ids='MPATH_458'>normal</z:mpath> gastrointestinal sites and also in association with <z:e sem="disease" ids="C0151785" disease_type="Disease or Syndrome" abbrv="">mucosal disease</z:e>, suggesting variable protective potential </plain></SENT>
<SENT sid="10" pm="."><plain>Such molecules could play a role in the development of gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath> by protecting areas of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="11" pm="."><plain>Conversely, parietal cells appeared to be potentially vulnerable targets for complement attack </plain></SENT>
</text></document>